Hikma buys US generic drugmaker Roxane for $2.65bn
London-listed pharmaceuticals firm Hikma on Tuesday bought US generic drugs company Roxane from German peer Boehringer Ingelheim for $2.65 billion (2.40 billion euros) in the sector`s latest rapid round of consolidation.
Jul 28, 2015, 15:59 PM IST